Autologous adipose-derived mesenchymal stem cells (AD-MSC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous adipose-derived mesenchymal stem cells (AD-MSC), covering 2015-04-03 to 2015-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia [Phase 1, Phase 2]